Your search

This condition, which has the full name of 'erythrocyanosis frigida crurum puella rum' (cold reddish blueness of the legs of girls), is extremely common. It is not always recognized, being misdiagnosed as lymphoedema, vasomotor disease, arterial insufficiency, and other things. The skin of the legs is cold to the touch and exhibits patches of bluish discoloration. There may be chilblains and small superficial ulcerated areas. There is often an abnormally large amount of fat particularly above the ankle and around the tendo Achillis. For this reason it is sometimes called ' lipoedema'. The affected patches are often hypersensitive to light touch and may irritate with changes of temperature. Deeper palpation may reveal tenderness and nodularity of the underlying fat. The condition is usually symmetrical or alsmost so. The feet often remain normal. At typical case is illustrated in Figs. 14.22 and 14.23

While the term cellulitis is incorrect, it is commonly used and deserves a nosological classification. "Cellulitis is a dermohypodermosis and an oedemato-sclerous panniculopathy- It is indeed a true histangiography in which the fibroblastic reaction predominates over capillaro-veinular changes. Adipocytes of exaggerated size interpenetrate into micro- and later into macronodules marked off by more or less structured conjunctive fibrilla, thereby making treatment difficult.

Systemic causes of leg edema include idiopathic cyclic edema, heart failure, cirrhosis, nephrosis and other hypoproteinemic states. Lymphedema may be primary, or secondary to neoplasm, lymphangitis, retroperitoneal fibrosis and, rarely (in the U.S.), filariasis. Thrombophlebitis and chronic venous insufficiency are not uncommon causes. Finally, infection, ischemia, lipedema, vascular anomalies, tumors and trauma can be responsible for the swollen leg.

En último término, el edema de los miembros se produce siempre a través de perturbaciones circulatorias. Estas alteraciones pueden tener un origen central o sistémico: afecciones cardiovasculares, renales, tiroideas o humorales (hipoproteinemia) y pueden también tener un origen periférico: insuficiencia venosa, linfoedema, etc. Uno de los problemas más difíciles de controlar para el médico es el edema de las piernas, de origen periférico, esto es sin relación con alteraciones cardiorrenales, tiroideas o humorales,. en otras palabras el edema consecutivo a la insuficiencia venosa que sucede como grave secuela a las flebotrombosis o flebitis, al linfoedema, etc. En los últimos años se ha avanzado bastante, sin embargo, en la prevención y en el tratamiento de estos edemas de origen periférico merced al mejor conocimiento de la fisiopatología, lo que supone un perfeccionamiento diagnóstico y a favor del uso de nuevos medios de tratamiento como ,los anticoagulantes y las vendas elásticas. Uno de los aportes más interesantes que se han hecho en el diagnóstico y diferenciación de estos sindromes es la descripción de una entidad clínica, hecha en Marzo de 1940 por dos investigadores de la Clínica Mayo: Allen y Hines que denominaron lipoedema de las piernas. Se trata de un aumento de volumen simétrico y generalizado de las piernas por aumento de los depósitos adiposos subcutáneos y por edema, que afecta casi exclusivameñte a las mujeres. A la descripción del cuadro clínico hecha en 1940 hemos sumado como antecedente bibliográfico un trabajo de conjunto que nos ha enviado directamente el Dr. Edgar v. Allen desde la Clínica Mayo, que no se ha publicado aún, y que reúne la experiencia de dicho servicio desde 1937 hasta 1946 .

Lipedema is a chronic, predominantly female disorder characterized by disproportionate regional expansion of subcutaneous adipose tissue, pain, tenderness and easy bruising. Although adipocyte hypertrophy, altered progenitor-cell behavior, microvascular dysfunction, extracellular-matrix remodeling, immune-cell alterations and variable lymphatic abnormalities have been reported, their causal and temporal relationships remain unresolved. Here, we propose that these findings may represent interacting manifestations of dysregulation within an adipovascular unit (AVU) rather than independent pathological processes.

Are you newly diagnosed with lipedema, a painful adipose tissue disorder? Maybe you have had the condition for years and are looking for ideas for self-care from a holistic perspective.In this book you will learn:Treatment goals for lipedema / lipoedemaTips for reducing pain and inflammationHow to boost your lymphatic systemIf you are looking for a research-packed guide to caring for lipedema, read this book!Praise for Lipedema Treatment Guide:Steven Dean, DO, FACP, RPVI, Professor of Clinical Internal Medicine, Ohio State University Wexner Medical Center calls the Lipedema Treatment Guide "incredibly well-written and informative" and has added it to his patient lipedema handout.Jacqui Beutel teaches Decongestive Lymphatic Therapy courses in Australia and New Zealand and gives copies of the Lipedema Treatment Guide to her students.

Software engineering plays a key role in developing high-quality healthcare systems, particularly in Precision Medicine, where advanced systems are required to tailor clinical interventions based on individual genetic, environmental, and lifestyle factors. Therefore, it is necessary to rethink software engineering methods to address the significant challenges in healthcare systems, especially in system design, complex data analysis, traceability, and AI explainability. This paper presents the MATIIGEN project, which aims to address these challenges. MATIIGEN introduces an intelligent system for automated DNA variant interpretation. The project combines Model-Driven Software Engineering (MDSE) principles with Explainable Artificial Intelligence (XAI) to support the transition of genomic tools from laboratory validation environments (TRL4) to operational clinical settings (TRL6). MDSE provides the structural and methodological basis for building robust, traceable, and interoperable software systems, and XAI provides mechanisms to make the system’s outputs more transparent and understandable to clinicians. The applicability of MATIIGEN platform is demonstrated through a historically overlooked chronic disease: Lipedema. By focusing on a condition that is under-researched in clinical settings, we can demonstrate that the MATTIGEN platform can generate insights in areas of medicine where data is scarce and complex. Our work demonstrates that adopting MDSE principles provides a systematic methodology for transforming multifaceted clinical data into actionable medical insights and establishes a scalable architecture for high-quality, software-intensive systems in the healthcare domain.

An evidence-based guide to current understanding of lipedema, its causes and possible treatments, addressing what is known through human studies, what is unknown and needs investigating, and what is likely to emerge. Lipedema (or lipoedema) is a chronic lymphatic disorder in which abnormal levels of fat build up disproportionately in certain areas of the body, most commonly the hips, bottom and legs. Almost exclusively affecting women, who may seek help for years only to be met with ongoing anti-fat stereotyping, its significant life-changing impact has only recently been recognized, clinically and in terms of research funding. Even though research is now accelerating, there is still much left to be discovered. This book brings together the current knowns, unknowns and conjectures as a comprehensive resource for researchers, clinicians and patients seeking a roadmap to potentially improving the lives of up to 17 million women in the US and 350 million worldwide.

Lipedema is a chronic and progressive disorder, a primary lipotrophy characterized by abnormal fat deposition, primarily in the buttocks and legs bilaterally. It is symmetrical and disproportionate. It is estimated to affect 10 to 18% of women in Europe and approximately 12.3% of the Brazilian female population.